Blog

The ‘Global Contract Development and Manufacturing Organisation (CDMO) Market Size, Share, Price, Trends, Growth, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of the global contract development and manufacturing organisation (CDMO) market, assessing the market on the basis of its segments like services, CMO, and CRO, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/contract-development-and-manufacturing-organization-cdmo-market/requestsample

Contract Development and Manufacturing Organisation (CDMO) Market Share, Size, Growth, Trends, Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2017-2027)

• Forecast CAGR (2022-2027): 8.4%

The thriving pharmaceutical industry is leading to a heightened deployment of CDMO for complex drug manufacturing processes, hence driving the market growth. CDMOs provide additional scientific, regulatory, and process expertise during the mass production of pharmaceutical products while bolstering the scalability of pharmaceutical companies.The increasing demand for drugs and medicines owing to the escalating cases of chronic diseases is driving the market growth. CDMOs support pharmaceutical companies to meet deadlines and rising demands by ramping up the production volume without the requirement of additional labour costs.

The increasing attempt by pharmaceutical companies to reduce infrastructural investment costs is further propelling the contract development and manufacturing organisation (CDMO) market growth.As CDMOs can both downsize and boost production capabilities, cell manufacturing is increasingly outsourced to CDMOs for increasing the scalability and commercialisation of cell and gene therapies. CDMO also streamlines the process of cell manufacturing while eradicating the requirement for contacting many vendors.

Over the forecast period, the growing competition between major pharmaceutical companies is likely to bolster the preference for CDMOs for product innovations. In addition to this, the end-to-end manufacturing services offered by CDMOs are anticipated to increase the manufacturing speed, further boosting the reliance on CDMOs.

In terms of region, North America accounts for a significant share of the contract development and manufacturing organisation (CDMO) market. The market is being driven by the increasing investments by CDMOs to expand their manufacturing capabilities in the United States and Canada. The increasing FDA approvals of drugs and medicines for the treatment of chronic diseases are further encouraging pharmaceutical companies to ramp up their production, hence fuelling the market for CDMO.

Contract Development and Manufacturing Organisation (CDMO) Market Definition and Major Segments

Contract development and manufacturing organisation (CDMO) is defined as a firm which collaborates with a pharmaceutical company to facilitate the outsourcing of drug manufacturing. The services provided by the CDMOs include formulation, packaging, serialisation, and shipment, among others. CDMO bolsters the production and innovation process which is beneficial for pharmaceutical companies.

Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/contract-development-and-manufacturing-organization-cdmo-market

Based on service, the market can be segmented into:

• CMO
• CRO

The market can be broadly categorised based on CMO into:

• API Manufacturing
• Finished Product Manufacturing
o Solid
o Liquid
o Injectable
• Packaging
• Others

By CRO, the market is segmented into:

• Discovery
• Preclinical
• Clinical
o Phase I
o Phase II
o Phase III
o Phase IV
• Laboratory Services
o Bioanalytical Services
o Analytical Services
• Others

On the basis of region, the market can be categorised into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Contract Development and Manufacturing Organisation (CDMO) Market Trends

The key trends in the contract development and manufacturing organisation (CDMO) market market include the growing research and development activities life sciences and in gene and cell therapy and the heightened investments to bolster the manufacturing efficiency of CDMOs.The increasing efforts by the pharmaceutical companies aimed towards enhancing their analytical capabilities are likely to surge their strategic collaborations with CDMOs in the forecast period.

Additionally, the contract development and manufacturing organisation (CDMO) market growth is expected to be aided by technological advancements in CDMOs, including the penetration of the Internet of things (IoT) and automated IT systems, which are expected to enhance R&D activities, accelerate drug delivery and development, and increase the overall efficiency in the pharmaceutical industry.The thriving e-commerce industry, which is bolstering the sale of therapeutic drugs and medications, is likely to be another crucial trend in the market.

The increasing sales of pharmaceutical products via various online platforms and the surging collaborations between pharmaceutical and biopharmaceutical companies and CDMOs for meeting their growing demand are some of the major factors driving the market growth.The increasing demand for unit doses, owing to their quick accessibility and efficient formulations, is anticipated to drive the growth of the market. Moreover, the introduction of aggressive vaccine development initiatives by various government, owing to the rising outbreak of chronic infections such as Monkeypox and elephantiasis, among others, is expected to positively influence the contract development and manufacturing organisation (CDMO) market development.

The market is expected to witness by the growing expansion activities of major key players. In May 2022, Hanmi Fine Chemical, a South Korean pharmaceutical company, announced the expansion of its manufacturing capabilities by including ‘high-tech’ CDMO services. Through this, the company is anticipated to offer quality CDMO services to cater to the growing demands of pharma and biopharmaceutical companies in the South Korean market.

Key Market Players

The major players in the contract development and manufacturing organisation (CDMO) market report are

• Lonza Group Ltd
• Catalent, Inc.
• Thermo Fisher Scientific, Inc.
• Jubilant Pharmova Ltd
• Aenova Holding GmbH
• Boehringer Ingelheim International GmbH
• Pfizer Inc.
• CordenPharma GmbH
• Recipharm AB
• Siegfried Holding AG
• Albany Molecular Research Inc.
• Fabbrica Italiana Sintetici S.p.A
• Fareva SA.
• Others.

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person:  Steven Luke, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
LinkedIn:- https://www.linkedin.com/company/expert-market-research